Researchers have discovered the novel mechanism that underlies a previously reported observation that infection by group A Streptococcus bacteria reduces the risk of later developing type 1 diabetes.
Type 1 diabetes arises through autoimmune destruction of insulin‐producing pancreatic β‐cells. MicroRNAs (miRNAs) have emerged as critical regulators at the interface of immune activation and β‐cell ...
Pathophysiology of Diabetes Mellitus: Understanding the Process and Complications : By Shayak Sanyal Key InsightsDiabetes is one of the most complex types of chronic diseases, which can have long-term ...
The adaptive immune system is an antigen-specific structure that discriminates non-self molecules through the recognition of peptide antigens using receptor interactions between T-cells and ...
A cross-sectional study reveals distinct inflammatory mediator profiles in gingival crevicular fluid and saliva from adults ...
Type 1 diabetes (T1D) is commonly diagnosed in childhood and the teen years. It’s a lifelong condition that requires treatment. Type 1 diabetes (T1D) is an autoimmune disease that occurs when the ...
Vaccination of neonatal mice with group A Streptococcus promotes clonal expansion of B cells that produce antibody against GlcNAc. The association of reduced Type 1 diabetes risk after group A ...